Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children

European Journal of Pediatrics

Volumn 156, Issue 2, 1997, Pages 90-93

  Kakourou, T ^a   Klontza, D ^a   Soteropoulou, F ^a   Kattamis, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

corticosteroids; erythema multiforme major; Stevens Johnson syndrome

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STEVENS JOHNSON SYNDROME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; PROSPECTIVE STUDIES; STEVENS-JOHNSON SYNDROME;

EID: 0031035645     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050561     Document Type: Article

References (17)

1. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC (1995) Erythema Multiformewith mucous membrane involvement and Stevens-Johnson Syndrome are clinically different disorders with distinct causes. Arch Dermatol 131: 539-543
2. Bastuji-Garin S, Rzany B, Stern R, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129: 92-95
3. Cathcart ES Idelson BA, Scheinberg MA, Couser WG (1976) Beneficial effects of methylprednisolone 'Pulse' therapy in diffuse proliferative lupus nephritis. Lancet I: 163-166
4. Friedmann PS, Strickland I, Pirmohamed M, Park K (1994) Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 130: 598-604
5. Ginsburg CM (1982) Stevens-Johnson syndrome in children. Pediatr Infect Dis 1: 155-158
6. Huff JC, Weston WL, Tonnesen MG (1983) Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 8: 763-775
7. Hurwitz S (1990) Erythema multiforme: a review of its characteristics, diagnostic criteria, and management. Pediatrics in Review 11: 217-229
8. Kazmierowski JA, Wuapper KD (1983) Erythema multiforme: Immune complex vasculitis of the superficial cutaneous microvasculature. J Invest Dermatol 81: 403-406
9. Laxer RM, Stein LD, Petty RE (1987) Intravenous pulse methylprednosolone treatment of juvenile dermatomyositis. Arthritis Rheum 30: 328-334
10. Mackel SE, Tappeiner G, Brumfield H, Jordon RE (1979) Circulating immune complexes in cutaneous vasculitis. J Clin Invest 64: 1652-1660
11. Margolis RJ,Tonnesen MG, Harrist TJ, Bhan AK, Wintroub BU, Mihm MC JR, Soter NA (1983) Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiforme. J Invest Dermatol 81: 403-406
12. Nethercott JR, Choi BCK (1985) Erythema multiforme (Stevens-Johnson syndrome) chart review of 123 hospitalized patients. Dermatologica 171: 383-396
13. Patterson R, Miller M, Kaplan M, Doan T, Brown J, Detjen P. Grammer LC, Greenberger PA, Hogan MB, Latall J, Lowenthal M, Pongracic J, Sonenthal K, R Zeiss (1994) Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy 73: 27-34
14. Rasmussen JE (1976) Erythema multiforme in children:-response to treatment with systemic corticosteroids. Br J Dermatol 95: 181-186
15. Special Symposium (1989) Corticosteroids for erythema multiforme? Pediatr Dermatol 6: 229-250
16. Ting HC, Adam BA (1984) Erythema multiforme: response to corticosteroids. Dermatologica 169: 175-178
17. Ting HC, Adam BA (1985) Stevens-Johnson syndrome: a review of 34 cases. Int J Dermatol 169: 175-178